RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/23006728http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/23006728http://www.w3.org/2000/01/rdf-schema#comment"Recent evidence suggested that ClC-3 channel/antiporter is involved in regulation of nuclear factor (NF)-κB activation. However, the mechanism explaining how ClC-3 modulates NF-κB signaling is not well understood. We hypothesized that ClC-3-dependent alteration of intracellular chloride concentration ([Cl(-)](i)) underlies the effect of ClC-3 on NF-κB activity in endothelial cells. Here, we found that reduction of [Cl(-)](i) increased tumor necrosis factor-α (TNFα)-induced expression of intercellular adhesion molecule 1 and vascular cell adhesion molecule 1 and adhesion of monocytes to endothelial cells (P<0.05; n=6). In Cl(-) reduced solutions, TNFα-evoked IκB kinase complex β and inhibitors of κBα phosphorylation, inhibitors of κBα degradation, and NF-κB nuclear translocation were enhanced. In addition, TNFα and interleukin 1β could activate an outward rectifying Cl(-) current in human umbilical vein endothelial cells and mouse aortic endothelial cells. Knockdown or genetic deletion of ClC-3 inhibited or abolished this Cl(-) conductance. Moreover, Cl(-) channel blockers, ClC-3 knockdown or knockout remarkably reduced TNFα-induced intercellular adhesion molecule 1 and vascular cell adhesion molecule 1expression, monocytes to endothelial cell adhesion, and NF-κB activation (P<0.01; n=6). Furthermore, TNFα-induced vascular inflammation and neutrophil infiltration into the lung and liver were obviously attenuated in ClC-3 knockout mice (P<0.01; n=7). Our results demonstrated that decrease of [Cl(-)](i) induced by ClC-3-dependent Cl(-) efflux promotes NF-κB activation and thus potentiates TNFα-induced vascular inflammation, suggesting that inhibition of ClC-3-dependent Cl(-) current or modification of intracellular Cl(-) content may be a novel therapeutic approach for inflammatory diseases."xsd:string
http://purl.uniprot.org/citations/23006728http://purl.org/dc/terms/identifier"doi:10.1161/hypertensionaha.112.198648"xsd:string
http://purl.uniprot.org/citations/23006728http://purl.uniprot.org/core/author"Liu J."xsd:string
http://purl.uniprot.org/citations/23006728http://purl.uniprot.org/core/author"Tao J."xsd:string
http://purl.uniprot.org/citations/23006728http://purl.uniprot.org/core/author"Yang H."xsd:string
http://purl.uniprot.org/citations/23006728http://purl.uniprot.org/core/author"Shang F."xsd:string
http://purl.uniprot.org/citations/23006728http://purl.uniprot.org/core/author"Huang L.Y."xsd:string
http://purl.uniprot.org/citations/23006728http://purl.uniprot.org/core/author"Liang S.J."xsd:string
http://purl.uniprot.org/citations/23006728http://purl.uniprot.org/core/author"Zeng D.Y."xsd:string
http://purl.uniprot.org/citations/23006728http://purl.uniprot.org/core/author"Zhou J.G."xsd:string
http://purl.uniprot.org/citations/23006728http://purl.uniprot.org/core/author"Wu Q.Q."xsd:string
http://purl.uniprot.org/citations/23006728http://purl.uniprot.org/core/author"Tang Y.B."xsd:string
http://purl.uniprot.org/citations/23006728http://purl.uniprot.org/core/author"Lv X.F."xsd:string
http://purl.uniprot.org/citations/23006728http://purl.uniprot.org/core/author"Guan Y.Y."xsd:string
http://purl.uniprot.org/citations/23006728http://purl.uniprot.org/core/author"Su Y.X."xsd:string
http://purl.uniprot.org/citations/23006728http://purl.uniprot.org/core/author"Huang E.W."xsd:string
http://purl.uniprot.org/citations/23006728http://purl.uniprot.org/core/author"Xiong L.X."xsd:string
http://purl.uniprot.org/citations/23006728http://purl.uniprot.org/core/date"2012"xsd:gYear
http://purl.uniprot.org/citations/23006728http://purl.uniprot.org/core/name"Hypertension"xsd:string
http://purl.uniprot.org/citations/23006728http://purl.uniprot.org/core/pages"1287-1293"xsd:string
http://purl.uniprot.org/citations/23006728http://purl.uniprot.org/core/title"Decrease of intracellular chloride concentration promotes endothelial cell inflammation by activating nuclear factor-kappaB pathway."xsd:string
http://purl.uniprot.org/citations/23006728http://purl.uniprot.org/core/volume"60"xsd:string
http://purl.uniprot.org/citations/23006728http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/23006728
http://purl.uniprot.org/citations/23006728http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/23006728